-
Tysabri, RRMS Treatment, May Promote Inflammatory B-Cell Activation, Study Says
A study of four DMTs for relapsing-remitting MS, largely T-cell targeting, found that Tysabri appears to affect pro-inflammatory B-cells as well. Click here to learn more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.